Report Claims Doctors Misuse Medical Codes to Bypass State Bans on Transgender Procedures

What's happening

A recent report from the medical watchdog group Do No Harm alleges that some doctors are using fraudulent medical coding practices to conceal transgender-related procedures from insurance companies and regulatory authorities. This alleged misuse involves substituting generic or unrelated diagnosis codes to mask treatments such as genital surgeries and hormone therapies, particularly for minors. The report suggests that these coding tactics enable healthcare providers to circumvent state-level bans on certain gender-affirming medical interventions. Such practices raise serious ethical questions about transparency, patient safety, and the effectiveness of regulatory oversight in healthcare.

Medical billing and reporting rely heavily on the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes, which categorize diagnoses and procedures for insurance reimbursement and public health data collection. According to the report, some providers are deliberately using endocrine disorder codes or other non-specific codes to disguise gender-affirming treatments. This allows them to both administer these interventions and receive insurance payments without triggering regulatory scrutiny. The practice reportedly extends to prescriptions for hormones like testosterone, which have been documented as being filled shortly after office visits lacking appropriate diagnosis codes.

The core controversy centers on the ethical implications of using misleading coding to facilitate medical procedures that are sometimes legally restricted, especially for children. Critics argue that this undermines the regulatory framework designed to protect vulnerable populations and ensure medical accountability. They contend that such actions could expose minors to irreversible treatments without adequate oversight or informed consent. On the other hand, supporters of gender-affirming care maintain that these interventions are crucial for alleviating gender dysphoria and improving the mental health and quality of life for transgender youth.

The report highlights that major organizations involved in transgender healthcare, including the World Professional Association for Transgender Health (WPATH), have acknowledged or even endorsed the use of endocrine-related ICD-10 codes for gender transition treatments and insurance billing. Additionally, advocacy groups such as the Campaign for Southern Equality have provided guidance encouraging the use of alternative coding to avoid scrutiny over sex-denying medical interventions. However, this guidance was reportedly removed from public access in March 2025 amid shifting political dynamics, raising questions about transparency and accountability in medical coding practices.

What's at stake

Kurt Miceli, chief medical officer at Do No Harm, expressed concern that medical diagnosis codes are being manipulated by ideological actors to evade proper reporting and regulatory oversight. He emphasized that hiding transgender procedures behind unrelated codes skirts ethical standards and potentially constitutes fraudulent billing. The report calls for increased regulatory vigilance to prevent misuse and protect patient safety, particularly for minors who may not fully comprehend the long-term consequences of these treatments.

Responses to the report have been mixed. Advocates for gender-affirming care argue that these medical interventions are essential and life-saving for many transgender individuals, especially youth experiencing gender dysphoria. Planned Parenthood of Southeastern Pennsylvania, for example, stated that the use of endocrine disorder codes is a common practice to meet the needs of patients and insurance companies, suggesting that such coding adaptations are widespread in the field. However, the report’s specific allegations about intentional misrepresentation have not been directly addressed by many providers or organizations involved.

The stakes in this issue are significant, involving the health and well-being of transgender minors, the integrity of medical billing systems, and the enforcement of state laws regulating healthcare. If the alleged coding misuse is widespread, it could undermine efforts by states to regulate gender-affirming care and complicate data collection on these procedures. Conversely, stricter oversight or changes in coding guidelines could impact access to care for transgender patients and providers’ ability to secure insurance reimbursement.

Looking ahead, the debate over transgender healthcare for minors is likely to intensify as lawmakers, regulators, and medical professionals grapple with how to balance patient rights, medical ethics, and legal restrictions. Potential next steps include increased audits of medical billing practices, revisions to ICD-10 coding guidelines, and legislative proposals aimed at clarifying or tightening regulations around gender-affirming care. Stakeholders will be watching closely how regulatory agencies respond and whether new policies emerge to address the concerns raised in the report.

Why it matters

Misuse of medical codes may allow providers to bypass state bans on gender-affirming procedures for minors. Such practices raise ethical concerns about patient safety and the integrity of regulatory oversight. Guidance encouraging alternative coding to avoid scrutiny has been withdrawn, highlighting transparency issues.

Supporters argue that gender-affirming treatments are critical for alleviating gender dysphoria and improving quality of life. The debate affects access to care, insurance reimbursement, and the enforcement of healthcare laws.

Key facts & context

Doctors reportedly use generic endocrine disorder ICD-10 codes to disguise transgender-related procedures. This coding practice can conceal genital surgeries and hormone treatments from insurers and regulators. The Campaign for Southern Equality provided guidance on alternative coding, removed from public view in March 2025.

WPATH training materials have endorsed endocrine-related codes for sex change treatments and billing. The report was published by Do No Harm, a medical watchdog group. Kurt Miceli is the chief medical officer at Do No Harm and a key spokesperson on this issue.

Planned Parenthood of Southeastern Pennsylvania acknowledges using endocrine disorder codes to meet insurance requirements. The ICD-10-CM system is used by the CDC and CMS for medical billing and health data tracking. Some prescriptions for testosterone were filled without appropriate diagnosis codes, raising concerns about coding legitimacy.

The report highlights potential fraudulent billing practices linked to these coding methods.

Timeline & key developments

2026-05-01: Report Claims Doctors Misuse Medical Codes to Bypass Bans on Transgender Procedures. Additional reporting on this topic is available in our broader archive and will continue to shape this timeline as new developments emerge.

Primary sources

• cdc.gov document
• cms.gov PDF

Further reading & references

• (Additional background links will appear here as we cover this topic.)